XML 82 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Operating Activities    
Net earnings (loss) $ 99,963,000 $ (26,064,000)
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation, depletion, accretion and amortization 137,702,000 152,557,000
Net gain on sale of property, plant & equipment and businesses (237,526,000) (40,550,000)
Contributions to pension plans (2,791,000) (2,308,000)
Share-based compensation 11,928,000 11,102,000
Excess tax benefits from share-based compensation (3,242,000) (888,000)
Deferred tax provision (benefit) 24,000 (31,581,000)
Cost of debt purchase 72,949,000 0
Changes in assets and liabilities before initial effects of business acquisitions and dispositions (59,893,000) (108,295,000)
Other, net 3,786,000 682,000
Net cash provided by (used for) operating activities 22,900,000 (45,345,000)
Investing Activities    
Purchases of property, plant & equipment (116,312,000) (60,041,000)
Proceeds from sale of property, plant & equipment 20,454,000 2,517,000
Proceeds from sale of businesses, net of transaction costs 719,089,000 52,908,000
Payment for businesses acquired, net of acquired cash (207,000) (89,951,000)
Increase in restricted cash (62,087,000) 0
Other, net 0 2,000
Net cash provided by (used for) investing activities 560,937,000 (94,565,000)
Financing Activities    
Proceeds from line of credit 0 111,000,000
Payment of current maturities, long-term debt and line of credit (579,694,000) (161,477,000)
Proceeds from issuance of common stock 27,539,000 0
Dividends paid (13,074,000) (2,598,000)
Proceeds from exercise of stock options 12,095,000 3,598,000
Excess tax benefits from share-based compensation 3,242,000 888,000
Other, net 1,000 0
Net cash used for financing activities (549,891,000) (48,589,000)
Net increase (decrease) in cash and cash equivalents 33,946,000 (188,499,000)
Cash and cash equivalents at beginning of year 193,738,000 275,478,000
Cash and cash equivalents at end of period $ 227,684,000 $ 86,979,000